Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
AHS Cancer Control Alberta
Takeda
Nuvation Bio Inc.
Tempus AI
Incyte Corporation
Actym Therapeutics, Inc.
Young Adult Survivors United
Bolt Biotherapeutics, Inc.
Sanofi
Eli Lilly and Company
University of Virginia
Hutchmed
NRG Oncology
Black Diamond Therapeutics, Inc.
Elevation Oncology
Turnstone Biologics, Corp.
Aminex Therapeutics, Inc.
Institut Cancerologie de l'Ouest
Tango Therapeutics, Inc.
NantCell, Inc.
Washington University School of Medicine
Columbia University
Pfizer
Medikine, Inc.
Ikena Oncology
Ikena Oncology
Spectrum Pharmaceuticals, Inc
Eisai Inc.
OHSU Knight Cancer Institute
Cellestia Biotech AG
Atreca, Inc.
Fusion Pharmaceuticals Inc.
Centre Hospitalier Universitaire de Besancon
pharmaand GmbH
Fate Therapeutics
Hoffmann-La Roche
Oncorus, Inc.
Incyte Corporation
Silverback Therapeutics
MacroGenics
Queen's University, Belfast
National Institutes of Health Clinical Center (CC)
ExcellaBio LLC
Hoffmann-La Roche
Advanced Accelerator Applications
Seagen Inc.
AIDS Malignancy Consortium
Case Comprehensive Cancer Center
Zhejiang Medicine Co., Ltd.